{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:05:29Z","timestamp":1792073129316,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["15UFEL25090280"],"award-info":[{"award-number":["15UFEL25090280"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK108833"],"award-info":[{"award-number":["R01DK108833"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK112826"],"award-info":[{"award-number":["R01DK112826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["2-SRA-2016-149-Q-R"],"award-info":[{"award-number":["2-SRA-2016-149-Q-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.celrep.2018.01.065","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T12:13:48Z","timestamp":1518524028000},"page":"1760-1773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic Mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Ankit X.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel B.","family":"Quittner-Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiuhwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May-yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie J.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andie C.","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Gordillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao V.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger H.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2018.01.065_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.molmet.2013.11.007","article-title":"Hypothalamic glucagon signals through the KATP channels to regulate glucose production","volume":"3","author":"Abraham","year":"2013","journal-title":"Mol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.molmet.2014.11.005","article-title":"Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction","volume":"4","author":"Ali","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib3","doi-asserted-by":"crossref","first-page":"H949","DOI":"10.1152\/ajpheart.00226.2001","article-title":"Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator","volume":"283","author":"Aasum","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.celrep.2018.01.065_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbrc.2014.04.031","article-title":"Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells","volume":"447","author":"Aw","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2018.01.065_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1210\/en.2008-0945","article-title":"The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action","volume":"150","author":"Ayala","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2018.01.065_bib6","first-page":"141","article-title":"Pancreatic extracts in the treatment of Diabetes Mellitus","volume":"12","author":"Banting","year":"1922","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.celrep.2018.01.065_bib7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM197706022962202","article-title":"Ketoacidosis in pancreatectomized man","volume":"296","author":"Barnes","year":"1977","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2018.01.065_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.CIR.0000083716.82622.FD","article-title":"Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice","volume":"108","author":"Barouch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.celrep.2018.01.065_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrendo.2011.77","article-title":"GLP-1 and energy balance: an integrated model of short-term and long-term control","volume":"7","author":"Barrera","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celrep.2018.01.065_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.celrep.2018.01.065_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrendo.2015.51","article-title":"Islet \u03b1 cells and glucagon--critical regulators of energy homeostasis","volume":"11","author":"Campbell","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celrep.2018.01.065_bib12","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","article-title":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK)","volume":"289","author":"Cao","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.01.065_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-016-0440-3","article-title":"Glucagon and heart in type 2 diabetes: new perspectives","volume":"15","author":"Ceriello","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.celrep.2018.01.065_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cmet.2017.04.010","article-title":"Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice","volume":"25","author":"Cokorinos","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00125-006-0481-3","article-title":"Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia","volume":"50","author":"Conarello","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.celrep.2018.01.065_bib16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cmet.2017.05.011","article-title":"Interrupted Glucagon Signaling Reveals Hepatic \u03b1 Cell Axis and Role for L-Glutamine in \u03b1 Cell Proliferation","volume":"25","author":"Dean","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/en.2012-1835","article-title":"Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db\/db mice","volume":"154","author":"Demarco","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2018.01.065_bib18","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","article-title":"Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice","volume":"100","author":"Gelling","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.01.065_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1124\/jpet.109.157685","article-title":"Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia","volume":"331","author":"Gu","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2018.01.065_bib20","doi-asserted-by":"crossref","first-page":"E624","DOI":"10.1152\/ajpendo.00102.2010","article-title":"Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor","volume":"299","author":"Gu","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib21","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1194\/jlr.M060897","article-title":"Glucagon receptor antagonism induces increased cholesterol absorption","volume":"56","author":"Guan","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2018.01.065_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrendo.2010.187","article-title":"The metabolic actions of glucagon revisited","volume":"6","author":"Habegger","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celrep.2018.01.065_bib23","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1210\/en.2004-0219","article-title":"Genetic background (C57BL\/6J versus FVB\/N) strongly influences the severity of diabetes and insulin resistance in ob\/ob mice","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2018.01.065_bib24","doi-asserted-by":"crossref","first-page":"10562","DOI":"10.1074\/jbc.M116.719666","article-title":"Activation of the cAMP-PKA pathway antagonizes metformin suppression of hepatic glucose production","volume":"291","author":"He","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.01.065_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in\u00a0vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.celrep.2018.01.065_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2018.01.065_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature17414","article-title":"Extra-helical binding site of a glucagon receptor antagonist","volume":"533","author":"Jazayeri","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.01.065_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc15-1643","article-title":"Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celrep.2018.01.065_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","article-title":"Is AMPK the savior of the failing heart?","volume":"26","author":"Kim","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2337\/db16-0530","article-title":"Enhanced muscle insulin sensitivity after contraction\/exercise is mediated by AMPK","volume":"66","author":"Kj\u00f8bsted","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.celrep.2018.01.065_bib31","doi-asserted-by":"crossref","first-page":"14393","DOI":"10.1073\/pnas.1206734109","article-title":"Molecular basis for negative regulation of the glucagon receptor","volume":"109","author":"Koth","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.01.065_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9258(19)75918-3","article-title":"Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents","volume":"262","author":"Kuroda","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.01.065_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/nm.2899","article-title":"MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity","volume":"18","author":"Kusminski","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2018.01.065_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0031-9384(87)90127-2","article-title":"Decreased feeding and supraphysiological plasma levels of glucagon after glucagon injection in rats","volume":"41","author":"Langhans","year":"1987","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.celrep.2018.01.065_bib35","doi-asserted-by":"crossref","first-page":"13624","DOI":"10.1073\/pnas.0405499101","article-title":"Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice","volume":"101","author":"Lee","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.01.065_bib36","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.1409638111","article-title":"Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.01.065_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cardiores.2005.04.018","article-title":"Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism","volume":"67","author":"Liao","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.celrep.2018.01.065_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.celrep.2018.01.065_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2008.09.008","article-title":"The glucagon receptor is required for the adaptive metabolic response to fasting","volume":"8","author":"Longuet","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0300-9084(91)90078-F","article-title":"New insights into the mitochondrial carnitine palmitoyltransferase enzyme system","volume":"73","author":"McGarry","year":"1991","journal-title":"Biochimie"},{"key":"10.1016\/j.celrep.2018.01.065_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.01.065_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","article-title":"Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation","volume":"7","author":"Mori","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.celrep.2018.01.065_bib43","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/en.2015-1011","article-title":"Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys","volume":"156","author":"Okamoto","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2018.01.065_bib44","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2018.01.065_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","article-title":"Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice","volume":"58","author":"Park","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.celrep.2018.01.065_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2337\/dci15-0033","article-title":"Clinical trials, triumphs, and tribulations of glucagon receptor antagonists","volume":"39","author":"Pearson","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celrep.2018.01.065_bib47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-2007-979981","article-title":"Physiological effect of glucagon in human isolated adipocytes","volume":"27","author":"Perea","year":"1995","journal-title":"Horm. Metab. Res."},{"issue":"Supplement 1","key":"10.1016\/j.celrep.2018.01.065_bib48","first-page":"A100","article-title":"REMD-477, a human glucagon receptor antibody, reduces daily insulin requirements and improves glycemic control in people with type 1 diabetes","volume":"66","author":"Pettus","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.celrep.2018.01.065_bib49","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1152\/ajpendo.00024.2003","article-title":"Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect","volume":"285","author":"Prigeon","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.molmet.2015.09.014","article-title":"Hypothalamic CaMKK\u03b2 mediates glucagon anorectic effect and its diet-induced resistance","volume":"4","author":"Qui\u00f1ones","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib51","doi-asserted-by":"crossref","first-page":"H125","DOI":"10.1152\/ajpheart.00165.2009","article-title":"Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus","volume":"297","author":"Radovits","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.celrep.2018.01.065_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib53","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2018.01.065_bib54","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.bmcl.2015.07.092","article-title":"Recent progress in the development of small-molecule glucagon receptor antagonists","volume":"25","author":"Sammons","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.celrep.2018.01.065_bib55","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cmet.2017.02.010","article-title":"Ceramide Is metabolized to Acylceramide and stored in lipid droplets","volume":"25","author":"Senkal","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib56","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib57","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/en.2003-0870","article-title":"Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome","volume":"144","author":"Unger","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2018.01.065_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3181\/00379727-102-25338","article-title":"Glucagon antibodies and their use for immunoassay for glucagon","volume":"102","author":"Unger","year":"1959","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.celrep.2018.01.065_bib59","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1152\/ajpendo.00004.2004","article-title":"Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone","volume":"288","author":"Wang","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/FJC.0000000000000054","article-title":"Heart failure and loss of metabolic control","volume":"63","author":"Wang","year":"2014","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.celrep.2018.01.065_bib61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2014.01.014","article-title":"Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway","volume":"156","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2018.01.065_bib62","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.1424934112","article-title":"Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.01.065_bib63","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2018.01.065_bib64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI16751","article-title":"Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy","volume":"111","author":"Yagyu","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2018.01.065_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.108.147009","article-title":"Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys","volume":"329","author":"Yan","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2018.01.065_bib66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yjmcc.2010.02.007","article-title":"Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice","volume":"49","author":"Zu","year":"2010","journal-title":"J.\u00a0Mol. Cell Cardiol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718301141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718301141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:18:29Z","timestamp":1761905909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124718301141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2211124718301141"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2018.01.065","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic Mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2018.01.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}